This activity is supported by educational grant from: AbbVie and Biohaven

Dawn C Buse, PhD - (Bio)

Diagnosis, Burden and Comorbidity of Migraines
Migraine is a common, chronic neurologic disease with episodic manifestations known as migraine attacks. Migraine can be associated with significant disability both during attacks as well as globally and has a range of comorbidities. The goal of this course is to provide an overview of the diagnostic criteria, burden and known migraine comorbidities as well as provide clinical insights into the diagnosis and management of migraine using a case example..
1 AMA PRA Category 1 Credit ™

To receive a Continuing Medical Education certificate, complete the pre-test, attend the presentation, complete the post-test, and the post-presentation evaluation.
Peter Goadsby, FRS, MD - (Bio)

Insights into the Genetics and Pathophysiology of Migraine
This educational course will outline the inherited basis of migraine insofar as it is currently understood. In order to understand and order treatment strategies, the module will outline the trigeminocervical anatomy and physiology and its interaction with cranial autonomic outflow pathway. The facilitates understanding many of the phenotypic manifestations of migraine that, when documented, facilitate the diagnosis. Non-headache symptoms that occur in the premonitory (prodromal) phase can be understood through an explanation of the known biology that again facilitates the clinical interaction and enhances management.

1 AMA PRA Category 1 Credit ™

To receive a Continuing Medical Education certificate, complete the pre-test, attend the presentation, complete the post-test, and the post-presentation evaluation.
Jessica Ailani, MD - (Bio)

Advances in the Preventive Treatment of Migraine
This session will discuss the use of preventive treatment in migraines. It will review when to discuss preventive strategies in patients with migraine and how to integrate discussions about lifestyle changes, behavioral management, and pharmacological preventive treatments in reaching a patient's goals of care. This talk will review new treatments in migraine prevention and how to use shared decision making when choosing prevention.
1 AMA PRA Category 1 Credit ™

To receive a Continuing Medical Education certificate, complete the pre-test, attend the presentation, complete the post-test, and the post-presentation evaluation.
Richard Lipton, MD - (Bio)

An Update on Diagnosis and Evolving Acute Treatments: Emphasis on Gepants
This lecture will summarize recently approved acute migraine treatments and the newer molecular entities such as Gepants (CGRP small molecule receptor blockers). We will discuss new drugs and migraine acute treatment ideas from the bench to the clinical trials, step 1. Following step 2 and Gepants: from clinical trials to clinical practice and the clinical roles of gepants in acute treatment. The course will touch on the goals of acute treatment of Migraines and providing rapid and consistent freedom from pain associated with symptoms without recurrence. Ultimately adding to the restored ability to function, minimizing the need for repeat dosing or rescue medications, and minimal or no adverse events.
1 AMA PRA Category 1 Credit ™

To receive a Continuing Medical Education certificate, complete the pre-test, attend the presentation, complete the post-test, and the post-presentation evaluation.
REGISTER
LOGIN